Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah's Witness. Issue 2 (26th December 2019)

• Record Type: Journal Article
• Authors: Rubinstein, Maria M.; Goss, Cheryl; Avecilla, Scott T.; Dubé, Gregory P.; Riely, Gregory J.; Mones, Jodi V.
• Is Part Of: Clinical case reports. Volume 8:Issue 2(2020)
• Page Start: 289
• Page End: 292
• Publication Date: 2019-12-26
• Subjects: hemoglobin‐based oxygen carrier -- hemopure -- pure red cell aplasia -- red blood cell alternatives; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.2626
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure ®, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient. Abstract : Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin‐based oxygen carrier, HBOC‐201 (HbO2 Therapeutics LLC; Hemopure ®, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient.